HENDERSON, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), a development stage company focused on the discovery, development and commercialization of therapeutic devices for patients with diabetes, announced that its Board of Directors has approved the grant of…
— Company looks for input from leading medical device design firm Las Vegas, Nevada, August 4, 2015, Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”) a development stage company focused on the discovery, development and commercialization of therapeutic…